The thyroid gland(external) produces thyroid hormones (TH), which are essential regulators for growth, development and metabolism. The thyroid is mainly controlled by the thyroid-stimulating hormone(external) (TSH) that binds to its receptor (TSHR) on thyrocytes(external) and mediates its action via different G protein-mediated signaling pathways(external). TSH primarily activates the G_s-pathway, and at higher concentrations also the G_q/11-pathway, leading to an increase of intracellular cAMP and Ca²⁺, respectively. To date, the physiological importance of other G protein-mediated signaling pathways in thyrocytes is unclear. Congenital hypothyroidism(external) (CH) is defined as the lack of TH at birth. In familial cases, high-throughput sequencing(external) methods have facilitated the identification of novel mutations. Nevertheless, the precise etiology(external) of CH yet remains unraveled in a proportion of cases. Genetically modified(external) mouse models can reveal new pathophysiological(external) mechanisms of thyroid diseases(external). Here, we will present an overview of genetic mouse models for thyroid diseases, which have provided crucial insights into thyroid gland development, function, and growth with a special focus on TSHR(external) and microRNA(external) signaling.